Dabrafenib Mesylate
Dabrafenib Mesylate is an anticancer drug (BRAF inhibitor).
| Catalog Number | API0232620 |
| Alternative Name(s) | Dabrafenib mesylate; 1195768-06-9; Taflinar |
| Research Area | API |
| Molecular Formula | C24H24F3N5O5S3 |
| CAS# | 1195768-06-9 |
| Inchi | InChI=1S/C23H20F3N5O2S2.CH4O3S/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25;1-5(2,3)4/h4-11,31H,1-3H3,(H2,27,28,29);1H3,(H,2,3,4) |
| Inchi Key | YKGMKSIHIVVYKY-UHFFFAOYSA-N |
| SMILES | CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F.CS(=O)(=O)O |
| Size | inquiry |
| Supplier Page | https://apihub.protheragen.ai/dabrafenib-mesylate-item-1120.html |
